In diabetic nephropathy, transforming growth factor beta 1 (TGF beta 1) is related to p38 mitogen-activated protein kinase (MAPK) that induces production of fibronectin in mesangial cells. We investigated the effects of a-lipoic acid (ALA), a potent antioxidant, on proteinuria and TGF beta 1-p38 MAPK-fibroncetin pathway in diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. After ALA treatment for 5 weeks in OLETF rats at 30 weeks of age, plasma malondialdehyde, Urinary protein excretion, renal cortical TGF beta 1, and fibronectin protein levels were decreased; and Urinary protein excretion was positively correlated with renal cortical TGF beta 1 and fibronectin protein levels. Phosphoform but riot total-form levels as welt as fold act...
Iron has been implicated in oxidative tissue injury owing to its ability to generate reactive oxygen...
The 12-lipoxygenase (12-LO) pathway of arachidonic acid metabolism is implicated in extracellular ma...
Introduction Diabetic nephropathy (DN) develops in about 40% of patients with type 2 diabetes and re...
α-Lipoic acid (ALA) is widely used as a nutritional supplement and therapeutic agent in diabetes man...
To evaluate the protective effects of α-lipoic acid on the kidneys of Goto-Kakisaki (GK) diabetic ra...
The aim of this study was to investigate whether alpha lipoic acid (LA) regulates high glucose-induc...
PURPOSE: The combined hyperglycemia lowering and antioxidant actions of α-lipoic acid (LA) contribut...
Abstract Objective: To evaluate the protective role of alpha lipoic acid in rats affected with expe...
Lithospermic acid B (LAB), an active component isolated from Salvia miltiorrhizae, has been reported...
Both hyperglycemia and hyperlipidemia increase oxidative stress, and contribute to the development o...
We aimed to investigate the protective effect of alpha lipoic acid (ALA), a powerful antioxidant, ag...
Abstract: Renal lipid metabolism may play important roles in renal inflammation, glomerulosclerosis ...
BACKGROUND: Angiotensin II (Ang II)-induced renal injury is associated with perivascular inflammatio...
Iron has been implicated in oxidative tissue injury owing to its ability to generate reactive oxygen...
Lipoic acid supplementation prevents angiotensin II–induced renal injury.BackgroundAngiotensin II (A...
Iron has been implicated in oxidative tissue injury owing to its ability to generate reactive oxygen...
The 12-lipoxygenase (12-LO) pathway of arachidonic acid metabolism is implicated in extracellular ma...
Introduction Diabetic nephropathy (DN) develops in about 40% of patients with type 2 diabetes and re...
α-Lipoic acid (ALA) is widely used as a nutritional supplement and therapeutic agent in diabetes man...
To evaluate the protective effects of α-lipoic acid on the kidneys of Goto-Kakisaki (GK) diabetic ra...
The aim of this study was to investigate whether alpha lipoic acid (LA) regulates high glucose-induc...
PURPOSE: The combined hyperglycemia lowering and antioxidant actions of α-lipoic acid (LA) contribut...
Abstract Objective: To evaluate the protective role of alpha lipoic acid in rats affected with expe...
Lithospermic acid B (LAB), an active component isolated from Salvia miltiorrhizae, has been reported...
Both hyperglycemia and hyperlipidemia increase oxidative stress, and contribute to the development o...
We aimed to investigate the protective effect of alpha lipoic acid (ALA), a powerful antioxidant, ag...
Abstract: Renal lipid metabolism may play important roles in renal inflammation, glomerulosclerosis ...
BACKGROUND: Angiotensin II (Ang II)-induced renal injury is associated with perivascular inflammatio...
Iron has been implicated in oxidative tissue injury owing to its ability to generate reactive oxygen...
Lipoic acid supplementation prevents angiotensin II–induced renal injury.BackgroundAngiotensin II (A...
Iron has been implicated in oxidative tissue injury owing to its ability to generate reactive oxygen...
The 12-lipoxygenase (12-LO) pathway of arachidonic acid metabolism is implicated in extracellular ma...
Introduction Diabetic nephropathy (DN) develops in about 40% of patients with type 2 diabetes and re...